Prostate Cancer
Prostate Cancer: is a cancer in a man's prostate, a small walnut-sized gland that produces seminal fluid. Some types of prostate cancer grow slowly, and other types are aggressive and require radiation, hormone therapy, surgery, chemotherapy, or other treatments.
C.E. CREDITS
Cancer disparities among persons of African descent are driven by both biological and nonbiological factors. There is evidence in breast cancer that psychosocial factors (environment, socioe...
C.E. CREDITS
Learning Objectives: 1. Understand the evolving epidemiology of prostate cancer in the the US and globally, and the excess burden of disease borne by men of African ancestry 2. Describe the...
OCT 07, 2020
6:00 AM PDT
C.E. CREDITS
OCT 07, 2020
6:00 AM PDT
This lecture will encompass the learning experience I have had over my 14,000 RALP cases. We will present an evidence based prospective data collection and analysis of RALP outcomes. We will...
C.E. CREDITS
Immune therapy approaches are being used in many different solid cancers today including clear cell renal carcinoma (mccRCC) and metastatic prostate adenocarcinoma. Over the past few years i...
SEP 23, 2020
10:30 AM PDT
C.E. CREDITS
SEP 23, 2020
10:30 AM PDT
Intestinal organoids are self-organizing, 3D structures derived from either pluripotent stem cells or from primary tissues with the abiltiy to recapitulate some of the spatial architecture a...
AUG 26, 2020
8:00 AM PDT
C.E. CREDITS
AUG 26, 2020
8:00 AM PDT
DATE: August 26, 2020 TIME: 8:00 am PDT The host immune "recognition" of cancer forms the basis of modern tumor immmunotherapy, a highly targeted treatment option with the demonstr...
JUL 14, 2020
7:00 AM PDT
C.E. CREDITS
JUL 14, 2020
7:00 AM PDT
ABSTRACT DATE: July 14, 2020 TIME: 7:00 am PDT, 10:00 am EDT This is the second topic in the webinar series on ‘ Predictive Genomics for Population & Personalized Health ’. C...
JUN 16, 2020
9:00 AM PDT
JUN 16, 2020
9:00 AM PDT
It is anticipated that the rapidly emerging era of data-driven precision medicine will require the development and delivery of new protein-based tests. Despite significant advances in the us...
JUN 03, 2020
6:00 AM PDT
C.E. CREDITS
JUN 03, 2020
6:00 AM PDT
Immune checkpoint therapies targeting the CTLA-4 and PD-(L)1 pathways have been largely clinically disappointing for patients with prostate cancer. This can be attributed to the highly immun...
